A pharmacoeconomic evaluation of results from the coronary angioplasty amlodipine restenosis study (CAPARES) in Norway and Canada
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 84 (1) , 23-30
- https://doi.org/10.1016/s0167-5273(02)00113-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the coronary AngioPlasty Amlodipine REStenosis Study (CAPARES)Journal of the American College of Cardiology, 2000
- AbciximabPharmacoEconomics, 1999
- Myocardial Revascularization for Chronic Stable AnginaAnnals of Internal Medicine, 1990
- Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipineAtherosclerosis, 1988
- Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.Circulation, 1988
- Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion sizeAtherosclerosis, 1988
- Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitroThrombosis Research, 1986
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984
- Effect of the Calcium-Entry Blocking Agent Nifedipine on Activation of Human Platelets and Comparison with VerapamilThrombosis and Haemostasis, 1983